Mortality and use of psychotropic medication in patients with stroke: A population-wide, register-based study

BMJ Open

Volumn 6, Issue 3, 2016, Pages

  Jennum, Poul ^a   Baandrup, Lone ^b   Iversen, Helle K ^a   Ibsen, Rikke ^c   Kjellberg, Jakob ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c I2minds   (Denmark)

^d KORA The Danish Institute for Local and Regional Government Research   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; NEUROLEPTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DENMARK; DRUG USE; FEMALE; HEALTH SERVICE; HEALTH STATISTICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL INFORMATION; MORTALITY; OUTCOME ASSESSMENT; CASE CONTROL STUDY; COMPLICATION; MENTAL DISORDERS; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; REGISTER; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; DENMARK; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; STROKE;

EID: 84961832160     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-010662     Document Type: Article

References (43)

1. Cox AM, McKevitt C, Rudd AG, et al. Socioeconomic status and stroke. Lancet Neurol 2006;5:181-8.
2. Andersen G, Vestergaard K, Riis J, et al. Incidence of post-stroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scale. Acta Psychiatr Scand 1994;90:190-5.
3. Mayer G, Jennum P, Riemann D, et al. Insomnia in central neurologic diseases-occurrence and management. Sleep Med Rev 2011;15:369-78.
4. Kripke DF, Klauber MR, Wingard DL, et al. Mortality hazard associated with prescription hypnotics. Biol Psychiatry 1998;43:687-93.
5. Rintoul AC, Dobbin MD, Nielsen S, et al. Recent increase in detection of alprazolam in Victorian heroin-related deaths. Med J Aust 2013;198:206-9.
6. Merlo J, Ostergren PO, Mansson NO, et al. Mortality in elderly men with low psychosocial coping resources using anxiolytic-hypnotic drugs. Scand J Public Health 2000;28:294-7.
7. Kripke DF, Langer RD, Kline LE. Hypnotics' association with mortality or cancer: A matched cohort study. BMJ Open 2012;2:e000850.
8. Mallon L, Broman JE, Hetta J. Is usage of hypnotics associated with mortality? Sleep Med 2009;10:279-86.
9. Jennum P, Baandrup L, Ibsen R, et al. Increased all-cause mortality with use of psychotropic medication in dementia patients and controls: A population-based register study. Eur Neuropsychopharmacol 2015;25:1906-13.
10. Montastruc F, Gardette V, Cantet C, et al. Potentially inappropriate medication use among patients with Alzheimer disease in the REAL. FR cohort: Be aware of atropinic and benzodiazepine drugs! Eur J Clin Pharmacol 2013;69:1589-97.
11. Lauterbach EC. Use of psychotropic medication in Alzheimer's disease is associated with more rapid cognitive and functional decline. Evid Based Med 2013;18:e50.
12. Rosenberg PB, Mielke MM, Han D, et al. The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. Int J Geriatr Psychiatry 2012;27:1248-57.
13. Vigen CL, Mack WJ, Keefe RS, et al. Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: Outcomes from CATIE-AD. Am J Psychiatry 2011;168:831-9.
14. Hermann DM, Bassetti CL. Sleep-related breathing and sleep-wake disturbances in ischemic stroke. Neurology 2009;73:1313-22.
15. Jorge RE, Robinson RG, Arndt S, et al. Mortality and poststroke depression: A placebo-controlled trial of antidepressants. Am J Psychiatry 2003;160:1823-9.
16. Mead GE, Hsieh CF, Hackett M. Selective serotonin reuptake inhibitors for stroke recovery. JAMA 2013;310:1066-7.
17. Wildenschild C, Mehnert F, Thomsen RW, et al. Registration of acute stroke: Validity in the Danish Stroke Registry and the Danish National Registry of Patients. Clin Epidemiol 2014;6:27-36.
18. Winkelmayer WC, Mehta J, Wang PS. Benzodiazepine use and mortality of incident dialysis patients in the United States. Kidney Int 2007;72:1388-93.
19. Allgulander C. Psychoactive drug use in a general population sample, Sweden: Correlates with perceived health, psychiatric diagnoses, and mortality in an automated record-linkage study. Am J Public Health 1989;79:1006-10.
20. Baandrup L, Jennum P, Lublin H, et al. Treatment options for residual insomnia in schizophrenia. Acta Psychiatr Scand 2013;127:81-2.
21. Bhalerao S, Seyfried LS, Kim HM, et al. Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder. J Geriatr Psychiatry Neurol 2012;25:29-36.
22. Marras C, Gruneir A, Wang X, et al. Antipsychotics and mortality in Parkinsonism. Am J Geriatr Psychiatry 2012;20:149-58.
23. Kales HC, Kim HM, Zivin K, et al. Risk of mortality among individual antipsychotics in patients with dementia. Am J Psychiatry 2012;169:71-9.
24. Honkola J, Hookana E, Malinen S, et al. Psychotropic medications and the risk of sudden cardiac death during an acute coronary event. Eur Heart J 2012;33:745-51.
25. Jackson CA, Mishra GD. Depression and risk of stroke in midaged women: A prospective longitudinal study. Stroke 2013;44:1555-60.
26. Majed B, Arveiler D, Bingham A, et al. Depressive symptoms, a time-dependent risk factor for coronary heart disease and stroke in middle-aged men: The PRIME Study. Stroke 2012;43:1761-7.
27. Nielsen TJ, Vestergaard M, Christensen B, et al. Mental health status and risk of new cardiovascular events or death in patients with myocardial infarction: A population-based cohort study. BMJ Open 2013;3:e003045.
28. Flaster M, Sharma A, Rao M. Poststroke depression: A review emphasizing the role of prophylactic treatment and synergy with treatment for motor recovery. Top Stroke Rehabil 2013;20:139-50.
29. Seifert CL, Poppert H, Sander D, et al. Depressive symptoms and the risk of ischemic stroke in the elderly-influence of age and sex. PLoS ONE 2012;7:e50803.
30. El Husseini N, Goldstein LB, Peterson ED, et al. Depression and antidepressant use after stroke and transient ischemic attack. Stroke 2012;43:1609-16.
31. Wang S, Linkletter C, Dore D, et al. Age, antipsychotics, and the risk of ischemic stroke in the Veterans Health Administration. Stroke 2012;43:28-31.
32. Pratt NL, Roughead EE, Ramsay E, et al. Risk of hospitalization for stroke associated with antipsychotic use in the elderly: A self-controlled case series. Drugs Aging 2010;27:885-93.
33. Glenn MB. Sudden cardiac death and stroke with the use of antipsychotic medications: Implications for clinicians treating individuals with traumatic brain injury. J Head Trauma Rehabil 2010;25:68-70.
34. Sacchetti E, Trifirò G, Caputi A, et al. Risk of stroke with typical and atypical anti-psychotics: A retrospective cohort study including unexposed subjects. J Psychopharmacol 2008;22:39-46.
35. Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: A systematic review and meta-analysis. JAMA Psychiatry 2015;72:334-41.
36. Tiihonen J, Mittendorfer-Rutz E, Torniainen M, et al. Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia: An observational follow-up study. Am J Psychiatry 2015. [Epub ahead of print 7 Dec 2015].
37. Gueye PN, Lofaso F, Borron SW, et al. Mechanism of respiratory insufficiency in pure or mixed drug-induced coma involving benzodiazepines. J Toxicol Clin Toxicol 2002;40:35-47.
38. Wilton LV, Heeley EL, Pickering RM, et al. Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine. J Psychopharmacol 2001;15:120-6.
39. Czekalla J, Kollack-Walker S, Beasley CM Jr. Cardiac safety parameters of olanzapine: Comparison with other atypical and typical antipsychotics. J Clin Psychiatry 2001;62:35-40.
40. Schuld A, Kraus T, Haack M, et al. Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REM-sleep-behavior disorder. J Sleep Res 1999;8:321-2.
41. Sivertsen B, Omvik S, Pallesen S, et al. Sleep and sleep disorders in chronic users of zopiclone and drug-free insomniacs. J Clin Sleep Med 2009;5:349-54.
42. Henderson A, Wright M, Pond SM. Experience with 732 acute overdose patients admitted to an intensive care unit over six years. Med J Aust 1993;158:28-30.
43. Mortensen JK, Larsson H, Johnsen SP, et al. Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: A nationwide propensity score-matched follow-up study. Stroke 2013;44:420-6.